(%)
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
- Ownership
-
Protagonist Therapeutics, Inc. Executive Compensation
* In original currency USD
Loading Data
|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total Amount |
|---|---|---|---|---|---|---|---|---|
| Tuesday, April 29th, 2025 | 2024 | Arturo Molina, M.D., M.S., F.A.C.P. Chief Medical Officer | 550,000 | 66,000 | 614,775 | 330,000 | 10,912 | 3,464,201 |
| Tuesday, April 29th, 2025 | 2024 | Suneel Gupta, Ph.D. Chief Development Officer | 530,500 | 63,660 | 450,835 | 291,775 | 10,912 | 2,735,526 |
| Tuesday, April 29th, 2025 | 2023 | Dinesh V. Patel, Ph.D. President and Chief Executive Officer | 655,200 | 0 | 0 | 360,360 | 10,912 | 7,067,572 |
| Tuesday, April 29th, 2025 | 2022 | Dinesh V. Patel, Ph.D. President and Chief Executive Officer | 630,000 | 0 | 897,813 | 242,550 | 10,912 | 5,993,238 |
| Tuesday, April 29th, 2025 | 2024 | Asif Ali EVP, Chief Financial Officer | 465,000 | 55,800 | 491,820 | 279,000 | 5,242 | 2,810,873 |
| Tuesday, April 29th, 2025 | 2023 | Asif Ali EVP, Chief Financial Officer | 447,000 | 0 | 129,306 | 178,800 | 5,242 | 1,402,215 |
| Tuesday, April 29th, 2025 | 2023 | Suneel Gupta, Ph.D. Chief Development Officer | 515,205 | 0 | 251,006 | 193,125 | 10,876 | 2,216,189 |
| Tuesday, April 29th, 2025 | 2024 | Dinesh V. Patel, Ph.D. President and Chief Executive Officer | 681,410 | 112,432 | 1,987,773 | 562,163 | 10,912 | 9,473,819 |
| Tuesday, April 29th, 2025 | 2022 | Suneel Gupta, Ph.D. Chief Development Officer | 500,000 | 0 | 359,125 | 130,000 | 10,894 | 2,684,804 |
| Wednesday, April 13th, 2022 | 2021 | David Y. Liu, Ph.D. Chief Research and Development Strategy Officer | 455,000 | 0 | 235,700 | 233,188 | 14,678 | 2,070,827 |
| Wednesday, April 13th, 2022 | 2021 | Dinesh V. Patel, Ph.D. President and Chief Executive Officer | 600,000 | 0 | 589,250 | 429,000 | 7,118 | 5,544,733 |
| Wednesday, April 13th, 2022 | 2020 | Suneel Gupta, Ph.D Chief Development Officer | 420,000 | 0 | 0 | 256,200 | 4,120 | 1,108,270 |
| Wednesday, April 13th, 2022 | 2021 | Suneel Gupta, Ph.D Chief Development Officer | 455,000 | 0 | 282,840 | 236,600 | 7,118 | 2,375,110 |
| Wednesday, April 13th, 2022 | 2020 | David Y. Liu, Ph.D. Chief Research and Development Strategy Officer | 441,300 | 0 | 0 | 266,987 | 11,133 | 1,071,849 |
| Wednesday, April 13th, 2022 | 2020 | Dinesh V. Patel, Ph.D. President and Chief Executive Officer | 565,000 | 0 | 0 | 473,894 | 3,573 | 2,225,622 |
| Wednesday, April 14th, 2021 | 2019 | Dinesh V. Patel, Ph.D. President and Chief Executive Officer | 545,000 | 0 | 230,575 | 354,250 | 4,164 | 1,948,344 |
| Wednesday, April 14th, 2021 | 2019 | Suneel Gupta, Ph.D. Chief Development Officer | 377,467 | 0 | 60,150 | 196,767 | 3,564 | 1,331,737 |
| Wednesday, April 14th, 2021 | 2019 | David Y. Liu, Ph.D. Chief Scientific Officer and Head of Discovery and Pre-Clinical Development | 428,450 | 0 | 120,300 | 218,509 | 7,458 | 1,199,598 |
| Wednesday, April 14th, 2021 | 2020 | David Y. Liu, Ph.D. Chief Scientific Officer and Head of Discovery and Pre-Clinical Development | 441,300 | 0 | 0 | 266,987 | 11,133 | 1,071,849 |
| Wednesday, April 14th, 2021 | 2020 | Suneel Gupta, Ph.D. Chief Development Officer | 420,000 | 0 | 0 | 256,200 | 4,120 | 1,108,270 |
| Wednesday, April 14th, 2021 | 2020 | Dinesh V. Patel, Ph.D. President and Chief Executive Officer | 565,000 | 0 | 0 | 473,894 | 3,573 | 2,225,622 |
| Thursday, April 16th, 2020 | 2019 | Suneel Gupta, Ph.D. Chief Development Officer | 377,467 | 0 | 60,150 | 196,767 | 3,564 | 1,331,737 |
| Thursday, April 16th, 2020 | 2018 | David Y. Liu, Ph.D. Chief Scientific Officer and | 410,000 | 0 | 382,389 | 141,500 | 7,458 | 1,618,355 |
| Thursday, April 16th, 2020 | 2019 | Dinesh V. Patel, Ph.D. President and Chief | 545,000 | 0 | 230,575 | 354,250 | 4,164 | 1,948,344 |
| Thursday, April 16th, 2020 | 2018 | Dinesh V. Patel, Ph.D. President and Chief | 520,000 | 0 | 1,127,739 | 221,000 | 10,844 | 3,721,511 |
| Thursday, April 16th, 2020 | 2019 | David Y. Liu, Ph.D. Chief Scientific Officer and | 428,450 | 0 | 120,300 | 218,509 | 7,458 | 1,199,598 |
| Thursday, April 16th, 2020 | 2018 | Suneel Gupta, Ph.D. Chief Development Officer | 0 | 0 | 0 | 0 | 98,105 | 98,105 |
| Friday, April 26th, 2019 | 2018 | David Y. Liu, Ph.D. Chief Scientific Officer and | 410,000 | 0 | 382,389 | 141,500 | 7,458 | 1,618,355 |
| Friday, April 26th, 2019 | 2018 | Richard S. Shames, M.D. Chief Medical Officer | 400,000 | 0 | 271,050 | 130,000 | 2,322 | 1,258,060 |
| Friday, April 26th, 2019 | 2017 | Richard S. Shames, M.D. Chief Medical Officer | 357,000 | 0 | 0 | 179,000 | 3,279 | 539,279 |
| Friday, April 26th, 2019 | 2017 | David Y. Liu, Ph.D. Chief Scientific Officer and | 357,000 | 0 | 0 | 186,000 | 9,168 | 552,168 |
| Friday, April 26th, 2019 | 2018 | Dinesh V. Patel, Ph.D. President and Chief | 520,000 | 0 | 1,127,739 | 221,000 | 10,844 | 3,721,511 |
| Friday, April 26th, 2019 | 2017 | Dinesh V. Patel, Ph.D. President and Chief | 475,000 | 0 | 0 | 309,000 | 6,088 | 790,088 |
| Wednesday, April 18th, 2018 | 2016 | Richard S. Shames, M.D. Chief Medical Officer | 326,000 | 0 | 0 | 96,578 | 420 | 1,332,531 |
| Wednesday, April 18th, 2018 | 2017 | Richard S. Shames, M.D. Chief Medical Officer | 357,000 | 0 | 0 | 179,000 | 3,279 | 539,279 |
| Wednesday, April 18th, 2018 | 2016 | David Y. Liu, Ph.D. Chief Scientific Officer and | 310,000 | 0 | 0 | 93,000 | 0 | 1,325,707 |
| Wednesday, April 18th, 2018 | 2017 | David Y. Liu, Ph.D. Chief Scientific Officer and | 357,000 | 0 | 0 | 186,000 | 9,168 | 552,168 |
| Wednesday, April 18th, 2018 | 2016 | Dinesh V. Patel, Ph.D. President and Chief | 400,000 | 0 | 0 | 160,000 | 0 | 4,990,240 |
| Wednesday, April 18th, 2018 | 2017 | Dinesh V. Patel, Ph.D. President and Chief | 475,000 | 0 | 0 | 309,000 | 6,088 | 790,088 |
| Monday, April 24th, 2017 | 2016 | David Y. Liu, Ph.D. Chief Scientific Officer and Head of Research Development | 310,000 | 0 | 0 | 93,000 | 0 | 1,325,707 |
| Monday, April 24th, 2017 | 2016 | Dinesh V. Patel, Ph.D. President and Chief Executive Officer | 400,000 | 0 | 0 | 160,000 | 0 | 4,990,240 |
| Monday, April 24th, 2017 | 2015 | Richard Shames, M.D. Chief Medical Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| Monday, April 24th, 2017 | 2016 | Richard Shames, M.D. Chief Medical Officer | 326,000 | 0 | 0 | 96,578 | 420 | 1,332,531 |
| Monday, April 24th, 2017 | 2015 | Dinesh V. Patel, Ph.D. President and Chief Executive Officer | 386,250 | 0 | 0 | 128,428 | 0 | 602,408 |
| Monday, April 24th, 2017 | 2015 | David Y. Liu, Ph.D. Chief Scientific Officer and Head of Research Development | 275,891 | 0 | 0 | 65,524 | 0 | 371,004 |
